Share Icon Health Study Area: Cardiovascular Disease Chevron Icon Health Study Area: Genitourinary For Patients Health Study Area: Lung Cancer Page Icon Phone Icon For Caregivers Health Study Area: AutoImmune Disease Health Study Area: Melanoma Location Icon Print YouTube Icon For Parents Health Study Area: Lung Cancer Print Created with Sketch. Help Icon Green Check Icon Search Icon Instagram Created with sketchtool. Direction Arrow Icon Error Icon For Parents Health Study Area: Blood Cancer Help Icon Health Study Area: NASH Gender Both Bookmark Icon Health Study Area: Melanoma Created with Sketch. Glossary Print Health Study Area: Blood Cancer Health Study Area: Genitourinary Health Study Area: Gastrointestinal Cancer Mobile Menu Icon Created with Sketch. Health Study Area: Cardiovascular Disease Health Study Area: Women's Cancer Communities Map Icon Created with Sketch. For Caregivers Health Study Area: Fibrosis Health Study Area: AutoImmune Disease FAQs Health Study Area: Head and Neck Cancer Created with Sketch. For Clinicians Chevron Right Icon Gender Female Health Study Area: Breast Cancer Direction Arrow Icon Gender Both Right Arrow Icon LinkedIn Icon Green Check Icon Gender Male Health Study Area: Fibrosis For Patients Twitter Icon Email Icon Facebook Icon Health Study Area: Gastrointestinal Cancer Health Study Area: Head and Neck Cancer For Clinicians External Link Icon

What is a Pan Tumor Clinical Trial?

A pan tumor clinical trial allows for multiple cancers to be treated within the same clinical trial.

About this approach

About this approach

Pan is a Greek term for ‘all’, thus a pan tumor clinical trial enrolls patients across a variety of tumor types.

A pan tumor clinical trial allows for multiple cancers to be treated within the same clinical trial.

You may have heard of these trials referred to as multi-tumor or basket trials. The purpose is to help accelerate the development of potential research options for patients with both commonly known and understudied cancers. This approach provides a faster way to assess safety and the effectiveness of experimental medications by analyzing unique biomarkers (an indicator in the body) that may indicate a response to the study drugs. This gives potential patients with different tumor types an opportunity to enroll into a clinical trial and receive research treatment options such as immunotherapy.

Patients diagnosed with solid tumors (a tumor that does not contain a cyst or liquid) and/or hematologic malignancies (blood cancer) may be eligible for pan tumor clinical trials.

Actively Recruiting Pan Tumor Trials

Individual study criteria and procedures must be met to enter into the clinical trial. The listed studies are actively recruiting. Please click on individual studies to see what tumors/conditions each study is recruiting for.

Not sure what trial might be right for you? Pre-screen now to see if there are clinical trials that might be right for you.

We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information

Have questions? Live support is available 24/7 - Call 855-907-3286 or email clinical.trials@bms.com

Have questions? Live support is available 24/7 -
Call 855-907-3286 or email clinical.trials@bms.com